Citations (12)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Rao Fu, Jake Gundrum & Anita H Sung. (2018) Health-care utilization and outcomes of patients at high risk of invasive fungal infection. ClinicoEconomics and Outcomes Research 10, pages 371-387.
Read now
Read now
Edoardo Bruno Vicenzi & Simone Cesaro. (2018) Posaconazole in immunocompromised pediatric patients. Expert Review of Anti-infective Therapy 16:7, pages 543-553.
Read now
Read now
Corrado Girmenia & Anna Paola Iori. (2017) An update on the safety and interactions of antifungal drugs in stem cell transplant recipients. Expert Opinion on Drug Safety 16:3, pages 329-339.
Read now
Read now
Articles from other publishers (9)
Arathi A Lambrix, Hope D Swanson, Jennifer L Pauley, Allison W Bragg, Delia C Carias, Melissa S Bourque, Yinmei Zhou, Cheng Cheng, William L Greene & Gabriela Maron. (2020) Experience using intravenous posaconazole in paediatric and young adult oncology patients. Journal of Antimicrobial Chemotherapy 75:12, pages 3682-3687.
Crossref
Crossref
Margherita Mauro, Antonella Colombini, Katia Perruccio, Daniele Zama, Maria Rosaria D'Amico, Elisabetta Calore, Francesca Carraro, Paola Muggeo, Gloria Tridello, Valentina Baretta & Simone Cesaro. (2020) Posaconazole delayed‐release tablets in paediatric haematology–oncology patients. Mycoses 63:6, pages 604-609.
Crossref
Crossref
Erika N. Wass, Elvin A. Hernandez & Caroline M. Sierra. (2020) Comparison of the Efficacy of Posaconazole Delayed Release Tablets and Suspension in Pediatric Hematology/Oncology Patients. The Journal of Pediatric Pharmacology and Therapeutics 25:1, pages 47-52.
Crossref
Crossref
Arthur W Baker, Eileen K Maziarz, Christopher J Arnold, Melissa D Johnson, Adrienne D Workman, John M Reynolds, John R Perfect & Barbara D Alexander. (2020) Invasive Fungal Infection After Lung Transplantation: Epidemiology in the Setting of Antifungal Prophylaxis. Clinical Infectious Diseases 70:1, pages 30-39.
Crossref
Crossref
Arjuna Nishantha Bandara Ellepola, Ranil Samantha Dassanayake & Ziauddin Khan. (2019) In vitro Post-Antifungal Effect of Posaconazole and Its Impact on Adhesion-Related Traits and Hemolysin Production of Oral <b><i>Candida dubliniensis</i></b> Isolates. Medical Principles and Practice 28:6, pages 552-558.
Crossref
Crossref
Carlos Solano & Lourdes Vázquez. (2018) Aspergilosis invasora en el paciente con enfermedad oncohematológica. Revista Iberoamericana de Micología 35:4, pages 198-205.
Crossref
Crossref
Edoardo Bruno Vicenzi, Elisabetta Calore, Nunzia Decembrino, Massimo Berger, Katia Perruccio, Francesca Carraro, Sara Rossin, Maria Caterina Putti, Mariadelfina Molinaro, Gloria Tridello & Simone Cesaro. (2018) Posaconazole oral dose and plasma levels in pediatric hematology-oncology patients. European Journal of Haematology 100:3, pages 315-322.
Crossref
Crossref
Diego O. Andrey, Laurent Kaiser, Stéphane Emonet, Veronique Erard, Yves Chalandon & Christian van Delden. (2017) Cerebral Rhizomucor Infection Treated by Posaconazole Delayed-Release Tablets in an Allogeneic Stem Cell Transplant Recipient. International Journal of Infectious Diseases 55, pages 24-26.
Crossref
Crossref
Kim Vanstraelen, Juergen Prattes, Johan Maertens, Katrien Lagrou, Hélène Schoemans, Nele Peersman, Pieter Vermeersch, Koen Theunissen, Raf Mols, Patrick Augustijns, Pieter Annaert, Martin Hoenigl & Isabel Spriet. (2016) Posaconazole plasma exposure correlated to intestinal mucositis in allogeneic stem cell transplant patients. European Journal of Clinical Pharmacology 72:8, pages 953-963.
Crossref
Crossref